CoChat

Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experience

CLOUSE, R. E., LUSTMAN, P. J., GEISMAN, R. A., ALPERS, D. H. · 1994 · Alimentary Pharmacology & Therapeutics
Cited by 163

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

SUMMARY: Background: Antidepressant agents may have a therapeutic role in functional gastroenterologic disorders, but controlled investigations in irritable bowel syndrome (IBS) have not provided satisfactory practice recommendations. To help with future study design, we reviewed a five‐year clinical experience with antidepressant agents in out‐patients with IBS. Methods: Presenting features, treatment course, and clinical outcome were determined from a chart review of 138 patients attending a university‐based gastroenterology practice. Results: Patients were treated with up to five antidepressants in separate, consecutive trials if a satisfactory end‐point had not been reached. Tricyclic antidepressants were utilized 130 times, newer antidepressants 39 times, and anxiolytic‐antidepressants 47 times. Improvement and complete remission in bowel symptoms occurred in 89% and 61% of patients, respectively, during antidepressant therapy. Median dosages being prescribed when remission occurred were less than those conventionally used in clinical psychiatry (50 mg/day for several tricyclic antidepressants). Age, gender, symptom duration, and presence of psychological symptoms did not discriminate those who remitted from those who did not, whereas a pain predominant symptom pattern was more commonly associated with symptom remission (P < 0.05 comparing symptom patterns). Symptom remission was more likely during the first antidepressant treatment than with subsequent trials in the group with continued symptoms (P = 0.01), but nearly half of the patients with side effects or no benefit from the first agent who went on to subsequent trials remitted during treatment with an alternative antidepressant. Conclusions: The design of this retrospective review is not capable of determining the efficacy of antidepressants for IBS. Our observations in conjunction with other available data suggest that future trials should employ low daily dosages, carefully assess pain response, include patients with and without active psychiatric symptoms, and utilize a second agent for subjects intolerant or unresponsive to the first.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.1994.tb00308.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 163

Metadata

Authors
CLOUSE, R. E., LUSTMAN, P. J., GEISMAN, R. A., & ALPERS, D. H.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1994-08
Volume
8
Issue
4
Pages
409-416
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2086563052
Cited by
163
References
1
FWCI
3.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experience. https://app.cochat.ai/papers/10.1111/j.1365-2036.1994.tb00308.x
The paper
CLOUSE, R. E., LUSTMAN, P. J., GEISMAN, R. A., & ALPERS, D. H. (1994). Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experience. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.1994.tb00308.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.